Insider Transactions Reported by 26 Insiders of Immunome Inc.

Symbol
IMNM on Nasdaq
Location
Bothell, WA

Insiders trading volume in the past year

Immunome Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isaac Barchas Director $46,797,554 -$8,330,080 -15% 22 Dec 2025
CLAY B. SIEGALL President and CEO, Director $18,344,810 +$3,411,017 +23% 30 Dec 2025
MICHAEL RAPP Director $7,564,292 02 Oct 2023
Philip Tsai Chief Technical Officer $887,216 +$308,466 +53% 19 Dec 2025
Max Rosett Chief Financial Officer $760,091 29 Jul 2025
Jack Higgins Chief Scientific Officer $627,633 19 Dec 2025
JOHN L. LAMATTINA Director $395,692 08 Jun 2023
FRANKLYN G. PRENDERGAST Director $359,564 02 Oct 2023
JEAN JACQUES BIENAIME Director $341,572 +$165,054 +94% 10 Jun 2025
Bruce Turner Chief Strategy Officer $249,993 09 Aug 2024
Michael Lefenfeld Director $240,815 08 Jun 2023
Robert Lechleider Chief Medical Officer $149,800 29 Jul 2025
Bob Lapetina PAO and VP Finance & Corporate $71,198 02 Jan 2024
Phil Noland Roberts Chief Technology Officer 13 Dec 2023
CAROL SCHAFER Director 10 Jun 2025
Sandra Stoneman Chief Legal Officer & Gc 29 Jul 2025
Purnanand D. Sarma President and CEO, Director 08 Jun 2023
Dennis H. Giesing Chief Development Officer 08 Jun 2023
Corleen Roche Chief Financial Officer 08 Jun 2023
Michael Widlitz Director 28 May 2021
MATTHEW K. ROBINSON Chief Technology Officer 08 Jun 2023
RICHARD A. BARON Director 08 Jun 2023
PHILIP WAGENHEIM Director 10 Jun 2025
SANDRA M. SWAIN Director 10 Jun 2025
James P. Boylan Director 10 Jun 2025
Kinney Horn Chief Business Officer 29 Jul 2025

Recent Insider Transactions by Companies or Individuals for Immunome Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.